Asarfi Hospital announced its financial results for the quarter ended June 30, 2026. Revenue from operations rose 33% year-over-year to ₹47.34 Cr, with a Profit After Tax of ₹4.27 Cr.

This strong performance, featuring an EBITDA margin of 20% and PAT margin of 9%, was driven by improved realizations, higher average revenue per occupied bed (ARPOB), and an enhanced case mix across both hospital units.

Inpatient revenue grew 37% and outpatient revenue increased 44% year-over-year, boosted by higher patient volumes.

Growth was particularly strong in high-acuity specialties and oncology care.